In last trading session, Artiva Biotherapeutics Inc (NASDAQ:ARTV) saw 0.35 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $11.11 trading at $1.11 or 11.10% at ring of the bell on the day assigns it a market valuation of $269.85M. That closing price of ARTV’s stock is at a discount of -55.81% from its 52-week high price of $17.31 and is indicating a premium of 12.87% from its 52-week low price of $9.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 47880.0 shares which gives us an average trading volume of 120.57K if we extend that period to 3-months.
Artiva Biotherapeutics Inc (NASDAQ:ARTV) trade information
Upright in the green during last session for gaining 11.10%, in the last five days ARTV remained trading in the green while hitting it’s week-highest on Tuesday, 12/17/24 when the stock touched $11.11 price level, adding 3.73% to its value on the day. Artiva Biotherapeutics Inc’s shares saw a change of -7.42% in year-to-date performance and have moved 4.61% in past 5-day. Artiva Biotherapeutics Inc (NASDAQ:ARTV) showed a performance of 1.37% in past 30-days. Number of shares sold short was 1.03 million shares which calculate 20.47 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 20.5 to the stock, which implies a rise of 45.8% to its current value. Analysts have been projecting 18 as a low price target for the stock while placing it at a high target of 23. It follows that stock’s current price would drop -62.02% in reaching the projected high whereas dropping to the targeted low would mean a loss of -62.02% for stock’s current value.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 60k for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -63.82% during past 5 years.
